Evidence map›Paper›PMID 30148160›Full record

ArticleNuclear receptor research2018

The Nuclear Receptor Field: A Historical Overview and Future Challenges.

Gisela I Mazaira, Nadia R Zgajnar, Cecilia M Lotufo, Cristina Daneri-Becerra, Jeffrey C Sivils, Olga B Soto, Marc B Cox, Mario D Galigniana

Abstract read
In one paragraph

Article in Nuclear receptor research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The expanding roles of Nr6a1 in development and evolution.Frontiers in cell and developmental biology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Exploring Ligand Binding Domain Dynamics in the NRs Superfamily.International journal of molecular sciences · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review ofFrontiers in endocrinology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gisela I MazairaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (1428), Argentina.
Nadia R ZgajnarInstituto de Biología y Medicina Experimental- CONICET. Buenos Aires (1428), Argentina.
Cecilia M LotufoInstituto de Biología y Medicina Experimental- CONICET. Buenos Aires (1428), Argentina.
Cristina Daneri-BecerraInstituto de Biología y Medicina Experimental- CONICET. Buenos Aires (1428), Argentina.
Jeffrey C SivilsDepartment of Biological Sciences and Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.
Olga B SotoDepartment of Biological Sciences and Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.
Marc B CoxDepartment of Biological Sciences and Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.
Mario D GalignianaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (1428), Argentina.

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

In this article we summarize the birth of the field of nuclear receptors, the discovery of untransformed and transformed isoforms of ligand-binding macromolecules, the discovery of the three-domain structure of the receptors, and the properties of the Hsp90-based heterocomplex responsible for the overall structure of the oligomeric receptor and many aspects of the biological effects. The discovery and properties of the subfamily of receptors called orphan receptors is also outlined. Novel molecular aspects of the mechanism of action of nuclear receptors and challenges to resolve in the near future are discussed.

Indexed as

ChaperonesHeat-shock proteinsHsp90Nuclear receptorSteroid receptorTranscriptional regulation

Identifiers

PMID30148160
PMCPMC6108593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.